Prevalence and Risk Factors of Diabetic Nephropathy in an Urban South Indian Population
The Chennai Urban Rural Epidemiology Study (CURES 45)
- Ranjit Unnikrishnan, I, MD,
- Mohan Rema, MBBS, DO, PHD,
- Rajendra Pradeepa, MSC,
- Mohan Deepa, MSC,
- Coimbatore Subramaniam Shanthirani, PHD,
- Raj Deepa, MPHIL, PHD and
- Viswanathan Mohan, MD, FRCP, PHD, DSC
- From the Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialties Centre, Gopalapuram, Chennai, India
- Address correspondence and reprint requests to Dr. V. Mohan, MD, FRCP, FRCP, PhD, DSc, Chairman and Chief of Diabetes Research, Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, 4 Conran Smith Rd., Gopalapuram, Chennai, 600 086, India. E-mail: drmohans{at}vsnl.net
Abstract
OBJECTIVE—The aim of this study was to determine the prevalence of diabetic nephropathy among urban Asian-Indian type 2 diabetic subjects.
RESEARCH DESIGN AND METHODS—Type 2 diabetic subjects (n = 1,716), inclusive of known diabetic subjects (KD subjects) (1,363 of 1,529; response rate 89.1%) and randomly selected newly diagnosed diabetic subjects (NDD subjects) (n = 353) were selected from the Chennai Urban Rural Epidemiology Study (CURES). Microalbuminuria was estimated by immunoturbidometric assay and diagnosed if albumin excretion was between 30 and 299 μg/mg of creatinine, and overt nephropathy was diagnosed if albumin excretion was ≥300 μg/mg of creatinine in the presence of diabetic retinopathy, which was assessed by stereoscopic retinal color photography.
RESULTS—The prevalence of overt nephropathy was 2.2% (95% CI 1.51–2.91). Microalbuminuria was present in 26.9% (24.8–28.9). Compared with the NDD subjects, KD subjects had greater prevalence rates of both microalbuminuria with retinopathy and overt nephropathy (8.4 vs. 1.4%, P < 0.001; and 2.6 vs. 0.8%, P = 0.043, respectively). Logistic regression analysis showed that A1C (odds ratio 1.325 [95% CI 1.256–1.399], P < 0.001), smoking (odds ratio 1.464, P = 0.011), duration of diabetes (1.023, P = 0.046), systolic blood pressure (1.020, P < 0.001), and diastolic blood pressure (1.016, P = 0.022) were associated with microalbuminuria. A1C (1.483, P < 0.0001), duration of diabetes (1.073, P = 0.003), and systolic blood pressure (1.031, P = 0.004) were associated with overt nephropathy.
CONCLUSIONS—The results of the study suggest that in urban Asian Indians, the prevalence of overt nephropathy and microalbuminuria was 2.2 and 26.9%, respectively. Duration of diabetes, A1C, and systolic blood pressure were the common risk factors for overt nephropathy and microalbuminuria.
- ACEI, ACE inhibitor
- ARB, angiotensin receptor blocker
- CURES, Chennai Urban Rural Epidemiology Study
- ESRD, end-stage renal disease
Footnotes
-
Published ahead of print at http://care.diabetesjournals.org on 8 May 2007. DOI: 10.2337/dc06-2554.
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.
-
- Accepted May 2, 2007.
- Received December 18, 2006.
- DIABETES CARE











